Search for: "Teva Pharmaceuticals USA Incorporated"
Results 1 - 20
of 34
Sorted by Relevance
|
Sort by Date
26 May 2015, 7:06 am
The court denied defendant's motion to reopen the judgment and rejected its argument that Teva Pharmaceuticals USA, Inc. v. [read post]
7 Dec 2014, 9:03 pm
Teva Pharmaceuticals USA Inc. 1:14-cv-01451; filed December 2, 2014 in the District Court of Delaware • Plaintiffs: Reckitt Benckiser Pharmaceuticals Inc.; RB Pharmaceuticals Ltd.; MonoSol Rx LLC • Defendant: Teva Pharmaceuticals USA Inc. [read post]
9 Oct 2009, 9:11 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
1 Dec 2009, 9:45 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
19 Jun 2019, 6:18 am
Teva Pharmaceuticals USA, Inc. [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ), (IPKat),… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy':… [read post]
11 May 2023, 1:16 pm
New Relists Teva Pharmaceuticals USA, Inc. v. [read post]
4 Sep 2010, 8:29 pm
Teva Pharmaceuticals USA (CAFC 2010-1005, 1033) precedential Teva argued the Bone Loss Patents and Low Dose Patent were obvious. [read post]
24 Sep 2010, 1:15 pm
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
31 Dec 2011, 1:00 pm
C-4329; and Teva Pharmaceuticals, Inc. and Cephalon, Dkt. [read post]
2 Sep 2010, 10:51 am
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
17 Mar 2020, 1:32 pm
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
